Surging US demand triggers new $2.9B purchase of Regeneron's Covid-19 antibodies

Regeneron has received a new $2.9 billion order for its Covid-19 antibody cocktail as demand for monoclonal antibodies surges in the US amid a spike in cases.

The US government is purchasing 1.4 million additional doses of REGEN-COV, a combination of casirivimab and imdevimab, at a price of $2,100 for each 1,200mg dose — bringing the total purchase to nearly 3 million doses.